-
日本語
-
English
RELATED PAPERS
Related papers of "Human Pancreatic Cancer Organoid Transplantation in Mice"
1. Tanaka C, Furihata K, Naganuma S, Ogasawara M, Yoshioka R, Taniguchi H, Furihata M, Taniuchi K. Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid. Hum Cell 35:735-744, 2022. doi: 10.1007/s13577-022-00684-7.
Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid - PubMed (nih.gov)2. Preparing...
Related papers of "Serum Diagnostic Markers for Pancreatic Cancer"
1. Taniuchi K, Tsuboi M, Sakaguchi M, Saibara T. Measurement of serum PODXL concentration for detection of pancreatic cancer. Onco Targets Ther 11:1433-1445, 2018. doi: 10.2147/OTT.S155367.
Measurement of serum PODXL concentration for detection of pancreatic cancer - PubMed (nih.gov)2. Taniuchi K, Okabayashi T, Sakaguchi M, Iwata J. Measurement of PODXL and SCGB1D2 for detecting intraductal papillary mucinous neoplasm. Nihon Shokakibyo Gakkai Zasshi 118:235-244, 2021. Japanese. doi: 10.11405/nisshoshi.118.235.
Measurement of PODXL and SCGB1D2 for detecting intraductal papillary mucinous neoplasm] - PubMed (nih.gov)Related papers of "Preoperative Chemotherapy NAC Biomarkers"
1. Taniuchi K, Furihata M, Naganuma S, Sakaguchi M, Saibara T. Overexpression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients. PLoS ONE 14:e0217920, 2019. doi: 10.1371/journal.pone.0217920.
Over expression of PODXL/ITGB1 and BCL7B/ITGB1 accurately predicts unfavorable prognosis compared to the TNM staging system in postoperative pancreatic cancer patients - PubMed (nih.gov)2. Taniuchi K, Ueno M, Yokose T, Sakaguchi M, Yoshioka R, Ogasawara M, Kosaki T, Naganuma S, Furihata M. Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients. PLoS ONE 17:e0265172, 2022. doi: 10.1371/journal.pone.0217920.
Upregulation of PODXL and ITGB1 in pancreatic cancer tissues preoperatively obtained by EUS-FNAB correlates with unfavorable prognosis of postoperative pancreatic cancer patients - PubMed (nih.gov)3. Taniuchi K, Furihata M, Naganuma S, Dabanaka K, Hanazaki K, Saibara T. Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin. Cancer Science 107:1430-1442, 2016. doi: 10.1111/cas.13018.
Podocalyxin-like protein, linked to poor prognosis of pancreatic cancers, promotes cell invasion by binding to gelsolin - PubMed (nih.gov)4. Preparing...
Related papers of "Serum Diagnostic Marker RNA for Pancreatic Cancer"
1. Kitagawa T, Taniuchi K, Tsuboi M, Sakaguchi M, Kohsaki T, Okabayashi T, Saibara T: Circulating pancreatic cancer exosomal RNAs detect pancreatic cancer. Mol Oncol 13:212-227, 2doi: 10.1002/1878-0261.12398.019.
Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer - PubMed (nih.gov)Related papers of "New Chemotherapy Regimens for Pancreatic Cancer"
1. Taniuchi K，Yawata T，Tsuboi M, Ueba T，Saibara T. Efficient delivery of small interfering RNAs targeting particular mRNAs into pancreatic cancer cells inhibits invasiveness and metastasis of pancreatic tumors. Oncotarget 10:2869-2886, 2019. doi: 10.18632/oncotarget.26880.
Efficient delivery of small interfering RNAs targeting particular mRNAs into pancreatic cancer cells inhibits invasiveness and metastasis of pancreatic tumors - PubMed (nih.gov)2. Jobu Y, Nishigawa M, Furihata K, Furihata M, Uchida K, Taniuchi K. Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors. Hum Cell 38:44, 2025. doi: 10.1007/s13577-024-01165-9.
Inhibitory effects of the combination of rapamycin with gemcitabine plus paclitaxel on the growth of pancreatic cancer tumors | Human CellRelated papers of "Drug Discovery for Pancreatic Cancer: Nucleic Acid Preparations"
1. Taniuchi K, Furihata M, Hanazaki K, Saito M, Saibara T. IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer. Oncotarget 5:6832-6845, 2014. doi: 10.18632/oncotarget.2257.
IGF2BP3-mediated translation in cell protrusions promotes cell invasiveness and metastasis of pancreatic cancer - PubMed (nih.gov)2. Taniuchi K, Furihata M, Saibara T. KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells. Neoplasia 16:1082-1093, 2014. doi: 10.1016/j.neo.2014.10.007.
KIF20A-mediated RNA granule transport system promotes the invasiveness of pancreatic cancer cells - PubMed (nih.gov)3. Taniuchi K，Yawata T，Tsuboi M, Ueba T，Saibara T. Efficient delivery of small interfering RNAs targeting particular mRNAs into pancreatic cancer cells inhibits invasiveness and metastasis of pancreatic tumors. Oncotarget 10:2869-2886, 2019. doi: 10.18632/oncotarget.26880.
Efficient delivery of small interfering RNAs targeting particular mRNAs into pancreatic cancer cells inhibits invasiveness and metastasis of pancreatic tumors - PubMed (nih.gov)4. Taniuchi K, Ogasawara M：KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer. Oncotarget 11:131-147, 2020. doi: 10.18632/oncotarget.27413.
KHSRP-bound small nucleolar RNAs associate with promotion of cell invasiveness and metastasis of pancreatic cancer - PubMed (nih.gov)5. Preparing...